IMC Chicago’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.97M Buy
30,400
+1,700
+6% +$254K ﹤0.01% 2451
2026
Q2
$4.37M Buy
28,700
+6,400
+29% +$1.07M ﹤0.01% 2236
2026
Q1
$4.68M Sell
22,300
-600
-3% -$151K ﹤0.01% 1832
2025
Q4
$6.51M Sell
22,900
-400
-2% -$125K ﹤0.01% 1537
2025
Q3
$7.19M Sell
23,300
-200
-0.9% -$62.7K ﹤0.01% 1336
2025
Q2
$7.38M Buy
23,500
+1,000
+4% +$289K ﹤0.01% 1177
2025
Q1
$5.91M Buy
22,500
+5,800
+35% +$1.57M ﹤0.01% 1142
2024
Q4
$4.36M Sell
16,700
-22,200
-57% -$5.59M ﹤0.01% 1322
2024
Q3
$9.05M Sell
38,900
-3,000
-7% -$616K ﹤0.01% 868
2024
Q2
$8.46M Buy
41,900
+17,900
+75% +$3.23M 0.01% 845
2024
Q1
$4.11M Buy
+24,000
New +$4.48M ﹤0.01% 1043

Other funds holding PODD

IMC Chicago's PODD Position: Q3 2026 in Review

IMC Chicago increased its Insulet (PODD) stake by 17% in Q3 2026, buying an estimated $540K and bringing the position to 25,402 shares worth $3.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

IMC Chicago first reported a position in PODD in Q3 2025 and has held it in 3 quarters since. The position peaked at $7.09M in Q3 2025. 694 funds tracked by Wall St. Rank hold PODD as of Q3 2026.

  • IMC Chicago held 25,402 shares of Insulet worth $3.31M as of Q3 2026.
  • IMC Chicago bought 3,607 Insulet shares in Q3 2026, an estimated $540K.
  • Insulet made up ﹤0.01% of IMC Chicago's portfolio in Q3 2026, its #2640 holding.
  • IMC Chicago first reported a position in Insulet in Q3 2025 and has held it in 3 quarters since.
  • IMC Chicago's Insulet position peaked at $7.09M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Insulet as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.